openPR Logo
Press release

Botanical and Plant Derived Drugs Market Trends Increases Steadily In Emerging Countries with Top Players GlaxoSmithKline, Pfizer, . Sanofi, Actelion, Aimil, Allergan, AstraZeneca

05-30-2019 01:35 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Botanical and Plant Derived Drugs

Botanical and Plant Derived Drugs

The botanical and plant derived drugs are obtained from medicinal plants, which contain algae, microscopic fungi or any vegetable material. They are used for treatment of various health conditions such as cardiovascular diseases, respiratory disease, central nervous system disorders, and infectious diseases. The major classes of botanical and plant derived drugs are Tarpenes and Steroids, Glycosides, Morphine Alkaloids, Ergot Alkaloids, and Vinca Alkaloids. High risk of side effects caused due to consumption of synthetic drugs such as allergic reaction and gastrointestinal upsets, drugs recalls, and high cost of specialty drugs are propelling the adoption of the botanical and plant derived drugs. Furthermore, increasing prevalence of chronic disease and low cost of botanical drugs are expected to foster the growth of botanical and plant derived drugs market.

However, stringent laws and regulations for approval of botanical drugs is a key restraint for the growth of botanical and plant derived drugs market.Moreover, increasing number of mergers and acquisitions by manufacturing companies is driving growth of the botanical and plant derived drugs market.

The botanical and plant derived drugs market is estimated to be valued at US$ 30.1 Bn in 2017, and is expected to witness a robust CAGR of 6.3% during the forecast period (2017 - 2026).

In several diseases, there is no cure for chronic pain. Therefore, physicians prefer pharmacologic methods to treat pain and decrease the suffering of patients. Patients suffering from intractable chronic pain, which cannot be managed with conventional treatment methods, prefer botanical and plant derived drugs. Lung cancer is the leading cause of death in the Eastern, Southern, and Southeastern Asia.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/1737

According to the 2013- International Agency for Research on Cancer data, in 2012, 1,033,881 cases of lung cancer occurred only in Asia. In addition, Eastern, Southern, and Southeastern Asia region accounts for 56% of the world’s population and contributes to 44% of the total cancer cases, worldwide according to the statistics mentioned in The Cancer Atlas. High cost of developing and manufacturing conventional drugs is propelling demand for alternative solution, such as plant-derived drugs that cost less than conventional drugs. Requirement of less technical experts and low capital investment for manufacturing botanical and plant-derived drugs. For instance, in October 2016, Napo Pharmaceuticals, Inc. launched Mytesi, an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on Antiretroviral Therapy (ART).

Furthermore, in February 2015, Nature’s Power Nutraceuticals (NP Nutra) launched seven new products, which include Aloe Vera 100:1 Freeze-dried (Organic), Yacon Leaf Powder (Organic), Nopal Powder (organic), Pea Protein Powder 80% (organic), Hemp Protein Powder 45% (organic), and NutraProtein Power Blend.

Favorable government policies and supportive initiatives by various organizations also aid in growth of the botanical and plant derived drugs market

Government is taking initiatives for the development of new plant-based drugs with herbal medicine gaining significant traction from the global healthcare systems. China utilizes herbal medicines for treatment of diseases such as acute respiratory syndrome. World Health Organization (WHO) along with economies such as India, China, the US, and Nigeria are majorly investing in research and development for herbal drugs.

Furthermore, legalization of medicinal cannabis is expected to boost growth of the botanical and plant derived drugs market. For instance, in 2016, marijuana legalization in America reached a tipping point as the medical marijuana became legal in some of the states. In February 2016, the Australian Government amended the Narcotics Drugs Act 1967 to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor growth of the botanical and plant derived market. The legalization of medicinal cannabis is expected to increase research on medicinal cannabis offering a valuable medical option for treatment, which in turn is supporting growth of botanical and plant derived drugs market in near future.

Key players operating in the market include Bayer Healthcare, GlaxoSmithKline, Pfizer, Inc. Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, and GW Pharmaceuticals.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1737

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Botanical and Plant Derived Drugs Market Trends Increases Steadily In Emerging Countries with Top Players GlaxoSmithKline, Pfizer, . Sanofi, Actelion, Aimil, Allergan, AstraZeneca here

News-ID: 1759384 • Views:

More Releases from Coherent Market Insights

Reusable Plastic Containers Market is Estimated to Witness High Growth Owing to Increased Environmental Awareness
Reusable Plastic Containers Market is Estimated to Witness High Growth Owing to …
Market Overview: Reusable plastic containers, also known as reusable transport packaging, are containers and dunnage designed for multiple uses in the transportation or distribution chains. These containers help reduce packaging waste and lower supply chain costs through reuse. Market Dynamics: Reusable plastic containers market is witnessing high growth owing to two key drivers - increased environmental awareness and cost savings for supply chain companies. Growing environmental concerns have pushed consumers and businesses to
Premium Potting Soils Market is Estimated to Witness High Growth Owing to Rising Demand from Commercial Horticulture Industry
Premium Potting Soils Market is Estimated to Witness High Growth Owing to Rising …
Market Overview: Premium potting soils are premium quality soils used for growing plants and vegetables indoors and outdoors. They contain high nutrient content and are formulated to retain adequate moisture and ensure proper drainage. Market Dynamics: Premium potting soils market is driven by rising demand from the commercial horticulture industry. The commercial horticulture industry is growing at a rapid pace owing to increasing consumption of fruits and vegetables along with cut flowers. According
Bromobenzene Market is Estimated to Witness High Growth Owing to Increasing Demand from Flame Retardant Applications
Bromobenzene Market is Estimated to Witness High Growth Owing to Increasing Dema …
Market Overview: Bromobenzene, also known as monobromobenzene, is an organobromine compound that is widely used in flame retardants, lubricating and cutting oils, intermediates in drugs and pesticides. It has a slightly sweet odor and is a colorless liquid. Market Dynamics: Bromobenzene is majorly used in flame retardants, which are added to plastics, textiles, and electronics to inhibit or resist the spread of fire. The demand for flame retardants from these end-use industries has
Indonesia Dietary Supplements Market is Estimated to Witness High Growth Owing to Rising Health Awareness Among Consumers
Indonesia Dietary Supplements Market is Estimated to Witness High Growth Owing t …
Market Dynamics: The Indonesia dietary supplements market is witnessing high growth owing to two major drivers - rising health awareness among consumers and growing middle-class population with higher disposable incomes. As consumers are increasingly focusing on preventive healthcare and wellness, the demand for dietary supplements to fulfill their daily nutrition requirements and remain healthy is growing. Moreover, Indonesia has a large young population with higher spending power on health and wellness

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.